Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

79Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Aims-To compare the efficacy of and tolerance to oral fluconazole and intraconazole in preventing fungal infection in neutropenic patients with haematological malignancies. Patients-213 consecutive, afebrile adult patients treated with or without autologous stem cell transplantation for haematological malignancies. Methods-A randomised, double blind, single centre study. Patients were randomly assigned to receive fluconazole 50 mg or itraconazole 100 mg, both twice daily in identical capsules. An intention to treat analysis was performed on 202 patients, 101 in each group. Results- Microbiologically documented systemic fungal infections occurred in four patients in each group. Clinical fungal infection was thought to be present in seven recipients of fluconazole and four of itraconazole. In all 202 patients, 29 proceeded to intravenous amphotericin (amphotericin B), 16 in the fluconazole group and 13 in the itraconazole group. Superficial fungal infection was seen only in three non-compliant patients in the fluconazole group. All these infections were oral. No major differences were noted in the isolates of fungi in mouth washes and fecal samples. Overall mortality was 8.9% (18 deaths; seven in the fluconazole group, 11 in the itraconazole group). Mortality from microbiologically and clinically documented fungal infection was 4.5% (nine deaths; three in the fluconazole group, six in the itraconazole group). Median time to suspected or proven fungal infection was 16 days in both groups. None of these comparisons reached statistical significance (p < 0.05). No major clinical toxicity was noted and compliance was excellent. Conclusions-In neutropenic patients treated for haematological malignancies with or without autologous stem cell transplantation, fluconazole and itraconazole in low doses result in a similar low frequency of fungal disease. Fluconazole may be the preferable drug because of the smaller number of capsules and lack of need for timing relative to meals.

References Powered by Scopus

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1104Citations
N/AReaders
Get full text

Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections

829Citations
N/AReaders
Get full text

Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia

818Citations
N/AReaders
Get full text

Cited by Powered by Scopus

European guidelines for primary antifungal prophylaxis in adult haematology patients: Summary of the updated recommendations from the European Conference on Infections in Leukaemia

299Citations
N/AReaders
Get full text

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis

261Citations
N/AReaders
Get full text

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: Evidence from a meta-analysis of 3,597 patients

245Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Huijgens, P. C., Simoons-Smit, A. M., Van Loenen, A. C., Prooy, E., Van Tinteren, H., Ossenkoppele, G. J., & Jonkhoff, A. R. (1999). Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. Journal of Clinical Pathology, 52(5), 376–380. https://doi.org/10.1136/jcp.52.5.376

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

44%

Researcher 6

33%

Lecturer / Post doc 3

17%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

68%

Biochemistry, Genetics and Molecular Bi... 3

14%

Pharmacology, Toxicology and Pharmaceut... 2

9%

Engineering 2

9%

Save time finding and organizing research with Mendeley

Sign up for free